Eli LIlly and Amgen have teamed up to scale manufacturing of future antibody cocktails, including Lilly's LY-CoV-55, in testing to treat COVID-19, the partners said Thursday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,